Literature DB >> 25290804

Fatigue and in vivo validation of a peritoneum-lined self-expanding nitinol stent-graft.

Jennifer M Bastijanic1, Jordan Etscheidt, Mallika Sattiraju, Craig Bonsignore, George Kopchok, Rodney White, Timur P Sarac.   

Abstract

PURPOSE: To assess the fatigue and in vivo performance of a new stent-graft incorporating bovine peritoneum lining that is designed for application in peripheral vascular occlusive disease.
METHODS: Bovine peritoneum-lined stent-grafts were subjected to accelerated in vitro pulsatile fatigue and axial/torsional fatigue testing designed to simulate 10 years of physiological strain on the devices. At specified times the devices were evaluated for stent fracture, suture failure, or tissue tearing. Seven dogs underwent bilateral common iliac artery (CIA) balloon angioplasty injury with unilateral placement of the peritoneum-lined stent-graft. Angiography and intravascular ultrasound were performed prior to treatment, after treatment, and prior to sacrifice at 30 days. Vessels were perfusion fixed and histologically evaluated at 5 regions: above stent, proximal stent, mid stent, distal stent, and below stent.
RESULTS: No evidence of stent, suture, or tissue failure was present during or after pulsatile and axial/torsional fatigue testing. At 30±0.3 days after implantation, all vessels were patent. The average lumen area at explantation across stented vessels was 25.45 mm(2). Lumen areas tended to be reduced above (23.57 mm(2)) and below (24.17 mm(2)) the stent. Lumen areas were consistent across stented regions at explantation (proximal stent 27.80 mm(2), mid stent 25.88 mm(2), and distal stent 25.81 mm(2)). The mean neointimal area in peritoneum-lined stents was 2.02±1.52 mm(2), with a neointima:media ratio of 1.03±0.50. These values were significantly lower in the above and below stent areas than in the stented regions, but there was no difference in either measure within the proximal, mid, or distal stent.
CONCLUSION: The custom-designed peritoneum-lined stent-graft is promising for clinical peripheral applications due to its ability to resist relevant long-term physiological stresses and outstanding short-term patency rates in canine implantations.

Entities:  

Keywords:  axial torsional fatigue; canine model; in vitro testing; in vivo experiment; neointimal hyperplasia; nitinol stent; peritoneum; pulsatile fatigue; self-expanding stent; stent-graft

Mesh:

Substances:

Year:  2014        PMID: 25290804      PMCID: PMC5621711          DOI: 10.1583/14-4762.1

Source DB:  PubMed          Journal:  J Endovasc Ther        ISSN: 1526-6028            Impact factor:   3.487


  15 in total

Review 1.  Drug-eluting stents: potential applications for peripheral arterial occlusive disease.

Authors:  Stephan H Duda; Tudor C Poerner; Benjamin Wiesinger; John H Rundback; Gunnar Tepe; Jakub Wiskirchen; Karl K Haase
Journal:  J Vasc Interv Radiol       Date:  2003-03       Impact factor: 3.464

2.  Remote superficial femoral artery endarterectomy and distal aSpire stenting: multicenter medium-term results.

Authors:  David Rosenthal; John D Martin; Peter J Schubart; Eric D Wellons; Frederick W Shuler; Adam B Levitt
Journal:  J Vasc Surg       Date:  2004-07       Impact factor: 4.268

3.  Effect of exercise on frequency of stent fracture in the superficial femoral artery.

Authors:  Osamu Iida; Shinsuke Nanto; Masaaki Uematsu; Takakazu Morozumi; Jun-ichi Kotani; Masaki Awata; Toshinari Onishi; Noriaki Ito; Fusako Sera; Hitoshi Minamiguchi; Hirokuni Akahori; Seiki Nagata
Journal:  Am J Cardiol       Date:  2006-06-06       Impact factor: 2.778

4.  Biological coating for arterial stents: the next evolutionary change in stents.

Authors:  Kevin Carnevale; Kenneth Ouriel; Yves Gabriel; Daniel Clair; James F Bena; Michael B Silva; Timur P Sarac
Journal:  J Endovasc Ther       Date:  2006-04       Impact factor: 3.487

5.  Autologous vein graft-coated stents for the treatment of thrombus-containing coronary artery lesions.

Authors:  C Stefanadis; E Tsiamis; C Vlachopoulos; K Toutouzas; C Stratos; I Kallikazaros; M Vavuranakis; P Toutouzas
Journal:  Cathet Cardiovasc Diagn       Date:  1997-02

6.  Sustained safety and effectiveness of paclitaxel-eluting stents for femoropopliteal lesions: 2-year follow-up from the Zilver PTX randomized and single-arm clinical studies.

Authors:  Michael D Dake; Gary M Ansel; Michael R Jaff; Takao Ohki; Richard R Saxon; H Bob Smouse; Scott A Snyder; Erin E O'Leary; Gunnar Tepe; Dierk Scheinert; Thomas Zeller
Journal:  J Am Coll Cardiol       Date:  2013-04-10       Impact factor: 24.094

7.  In vivo and mechanical properties of peritoneum/fascia as a novel arterial substitute.

Authors:  Timur P Sarac; Kevin Carnevale; Nickolas Smedira; Eugene Tanquilut; Peter Augustinos; Ankita Patel; Theresa Naska; Daniel Clair; Kenneth Ouriel
Journal:  J Vasc Surg       Date:  2005-03       Impact factor: 4.268

8.  In vivo femoropopliteal arterial wall compliance in subjects with and without lower limb vascular disease.

Authors:  N R Tai; A Giudiceandrea; H J Salacinski; A M Seifalian; G Hamilton
Journal:  J Vasc Surg       Date:  1999-11       Impact factor: 4.268

9.  Sirolimus-eluting stents for the treatment of obstructive superficial femoral artery disease: six-month results.

Authors:  Stephan H Duda; Benjamin Pusich; Goetz Richter; Peter Landwehr; Vincent L Oliva; Alexander Tielbeek; Benjamin Wiesinger; Jan Bart Hak; Hans Tielemans; Gerhard Ziemer; Ecatarina Cristea; Alexandra Lansky; Jean P Bérégi
Journal:  Circulation       Date:  2002-09-17       Impact factor: 29.690

10.  Percutaneous treatment of long superficial femoral artery occlusive disease: efficacy of the Hemobahn stent-graft.

Authors:  Peter J Bray; William J Robson; Alan E Bray
Journal:  J Endovasc Ther       Date:  2003-06       Impact factor: 3.487

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.